📊 Key Data
  • 40% year-over-year growth in 2026 for Jarrard, serving 200 clients nationally.
  • $1 billion in state-directed payment funding secured by Jarrard for hospitals.
  • $33.6 trillion projected federal health insurance subsidies over the next decade, per the Congressional Budget Office.
🎯 Expert Consensus

Experts would likely conclude that healthcare systems are shifting focus to federal PR due to increasing regulatory pressures and the need to protect revenue streams in a rapidly changing policy landscape.

about 7 hours ago
The Strategic Pivot: Why Healthcare Systems Are Escalating Federal PR

The Strategic Pivot: Why Healthcare Systems Are Escalating Federal PR

WASHINGTON, D.C. – October 20, 2026

For decades, the conventional wisdom in healthcare advocacy was that all healthcare is local. Hospital systems and regional providers built their political capital in statehouses, focusing their lobbying dollars on Medicaid expansion, certificate of need laws, and state-directed payment funding. But the flows of power that govern the American healthcare system are shifting rapidly. The real battlefield has moved to the banks of the Potomac, and the strategic communications industry is rushing to arm the combatants.

The latest signal of this systemic shift comes from Jarrard, a specialized healthcare consulting firm based in Nashville. Today, the agency announced a significant expansion of its national public affairs practice, planting a flag in Washington, D.C., and bringing on veteran political strategist Byron Johnson as senior vice president.

While a single agency opening a D.C. office might typically be dismissed as routine corporate growth, Jarrard's move is highly symptomatic of a broader, urgent realignment in the healthcare sector. As federal regulators tighten the screws on hospital pricing, nonprofit tax exemptions, and industry consolidation, healthcare executives are realizing that state-level relationships are no longer sufficient to protect their margins or their reputations.

The Strategic Communications Arms Race

Jarrard, which operates as a division of the national healthcare advisory firm Chartis, has built a formidable reputation over the last twenty years by mastering the local and state-level dynamics of healthcare policy. The firm has successfully navigated high-stakes campaigns involving medical malpractice legislation and helped hospitals secure over $1 billion in state-directed payment funding.

However, the firm's leadership recognizes that the lines between local reputation and federal policy have fundamentally blurred. To navigate this new reality, Jarrard has tapped Johnson, a seasoned operative with more than 25 years of experience in healthcare policy, coalition building, and crisis communications. Johnson's resume includes senior leadership stints at established Beltway heavyweights like FleishmanHillard, Widmeyer Communications, and 720 Strategies.

"Byron brings deep Washington experience, sound judgment and a rare ability to see the full field – from policy and public opinion to reputation and organizational dynamics," said Jarrard President and Co-founding Partner Anne Hancock Toomey. "He's exactly the right leader to grow this specialty in the Jarrard way: with integrated thinking, practical counsel and unwavering focus on what matters most to our clients."

The expansion is backed by significant momentum. The 20-year-old firm reported nearly 40 percent year-over-year growth in 2026, serving 200 clients nationally and adding more than 30 healthcare advisors to its roster. Over the past 18 months, its parent company has heavily capitalized Jarrard's public affairs specialty, strengthening its capabilities in digital advocacy, stakeholder activation, and grassroots mobilization.

The Catalysts: Antitrust, Transparency, and Tax Status

To understand the strategic rationale behind this Beltway pivot, one must look at the unprecedented regulatory onslaught currently facing healthcare organizations. The federal government is no longer just a primary payer through Medicare and Medicaid; it has become an aggressive auditor of hospital business practices.

First, nonprofit hospitals are facing existential scrutiny regarding their tax-exempt status. Recent reports from the Congressional Research Service highlighted that many nonprofit systems provide community benefits that fall well below the value of their tax subsidies. This has fueled legislative efforts like the Tax Exempt Hospital Transparency Act, which aims to force hospitals to mathematically justify their nonprofit status. For hospital boards, this is not merely a compliance issue—it is a foundational threat to their operating models.

Second, the Federal Trade Commission's newly minted Healthcare Task Force has dramatically escalated antitrust enforcement. The second Trump administration has maintained a surprisingly aggressive posture against healthcare consolidation, targeting exclusionary conduct and regional monopolies that allegedly raise prices or restrict access to care.

Furthermore, the Centers for Medicare & Medicaid Services (CMS) has renewed its push for site-neutral payments, a policy that would pay the same rate for services regardless of whether they are performed in a hospital outpatient department or a physician's office. Coupled with the strict enforcement of Hospital Price Transparency requirements that took effect earlier this year, hospital revenues are under siege from every angle.

"The stakes for healthcare leaders have never been higher," noted Isaac Squyres, senior partner at Jarrard, who has long directed the firm's issue navigation work. "They need to move beyond reacting to policy changes to anticipating political risk, beyond isolated advocacy to coordinated campaigns and beyond episodic engagement to building lasting trust and influence. That's what we are investing in, and that's what our clients need."

Bridging the Gap Between Statehouses and Capitol Hill

As healthcare systems escalate their federal PR spending, traditional state-focused consultancies are being forced to build inside-the-Beltway infrastructure. Jarrard's entry into the D.C. market places it in direct competition with entrenched public affairs powerhouses like FTI Consulting, APCO, and Edelman.

However, Jarrard is betting that its deep roots in local healthcare markets will provide a distinct competitive advantage. The firm has advised more than 1,800 clients across 49 states since its founding in 2006. By combining this localized network with its Market Research & Insights (MRI) practice—which boasts more than six years of national and local-market data—the firm aims to engineer highly targeted, research-backed grassroots campaigns that resonate on Capitol Hill.

As one veteran healthcare government relations officer noted recently, the traditional D.C. lobbying playbook is losing its efficacy. Lawmakers are increasingly immune to standard white papers and lobbyist dinners. To move the needle on federal healthcare policy today, organizations must demonstrate mobilized, vocal support from the voters and patients in a lawmaker's home district. The firms that can seamlessly connect local patient outrage or community support to federal legislative action are the ones that will dominate the next decade of healthcare public affairs.

Anticipating the Next Era of Political Risk

The financial pressures on the healthcare industry are expected to compound in the coming years. The Congressional Budget Office projects federal subsidies for health insurance to reach $33.6 trillion over the next decade, a staggering sum that guarantees continuous congressional attempts to slash provider reimbursements.

Simultaneously, new Medicaid eligibility and enrollment rules under the sweeping "One Big Beautiful Bill Act" are expected to drastically increase uncompensated care costs for hospitals. In rural areas, the financial strain is even more acute, with the administration now tying federal funding to state-level changes in Certificate of Need laws through the Rural Health Transformation Program.

In this volatile environment, public affairs is no longer a defensive mechanism deployed solely for crisis management. It is an offensive weapon necessary for survival. Healthcare organizations must proactively shape the policies that dictate their revenue streams, or they will be crushed by them.

Jarrard's expansion into Washington is a clear indicator that the industry understands this new paradigm. As business, policy, and reputation become increasingly inseparable, the quiet moves made by strategic communications firms today will heavily influence the regulatory frameworks of tomorrow. The battle for the future of American healthcare is being waged right now, and the front line is no longer in the hospital ward—it is in the hearing rooms and digital campaign trails of the nation's capital.

Topics & Related

Event:
Expansion
Leadership Change
Theme:
Antitrust
Sector:
Management Consulting
Marketing Services
Hospitals & Health Systems

📝 This article is still being updated

Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.

Contribute Your Expertise →
UAID: 52677